- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03309579
SAHaRA: A Randomized Controlled Trial
Aneurysmal Subarachnoid Hemorrhage - Red Blood Cell Transfusion and Outcome (SAHaRA): A Randomized Controlled Trial
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Shane English, MD MSc FRCPC
- Phone Number: 72818 (613) 737-8899
- Email: senglish@toh.ca
Study Locations
-
-
New South Wales
-
Newtown, New South Wales, Australia
- Recruiting
- The George Institute
-
-
-
-
Alberta
-
Calgary, Alberta, Canada
- Recruiting
- Foothills Medical Center
-
Edmonton, Alberta, Canada
- Recruiting
- University of Alberta Hospital
-
-
British Columbia
-
Vancouver, British Columbia, Canada
- Recruiting
- Vancouver General Hospital
-
Victoria, British Columbia, Canada
- Recruiting
- Royal Jubilee Hospital
-
-
Manitoba
-
Winnipeg, Manitoba, Canada
- Recruiting
- Winnipeg Health Sciences Center
-
-
Ontario
-
Hamilton, Ontario, Canada
- Recruiting
- Hamilton Health Sciences Center
-
Kingston, Ontario, Canada
- Recruiting
- Kingston Health Sciences Centre
-
London, Ontario, Canada
- Recruiting
- London Health Sciences Center
-
Ottawa, Ontario, Canada, K1Y 4E9
- Recruiting
- Shane English
-
Contact:
- Shane English, MD MSc FRCPC
- Phone Number: 72818 613-737-8899
- Email: senglish@ohri.ca
-
Toronto, Ontario, Canada
- Recruiting
- Sunnybrook Research Institute
-
-
Quebec
-
Montréal, Quebec, Canada
- Recruiting
- Centre Hospitalier de l'Universite de Montreal
-
Montréal, Quebec, Canada
- Recruiting
- Montreal Neurological Institute and Hospital
-
Québec City, Quebec, Canada
- Recruiting
- Centre Hospitalier Universitaire de Québec-Université Laval
-
Sherbrooke, Quebec, Canada
- Recruiting
- Centre Hospitalier Universitaire de Sherbrooke
-
-
-
-
Georgia
-
Atlanta, Georgia, United States, 30322
- Recruiting
- Emory University School of Medicine
-
-
Illinois
-
Chicago, Illinois, United States, 60612
- Recruiting
- Rush University Medical Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Age ≥18 years old at time of SAH
- First ever episode of aneurysmal SAH
- Diagnosis of aSAH as confirmed by treating physician (eg: neurosurgeon or neuro- interventionalist) and supported by blood in subarachnoid space (e.g. cranial imaging or cerebrospinal fluid positive for xanthochromia, surgical visualization) that is the result of a ruptured aneurysm (e.g. direct visualization, cranial imaging or catheter angiogram)
- Hb ≤100g/L within 10 days following aSAH (defined by first day of hospital presentation)
Exclusion Criteria:
- Physician and or family decision to withdraw/withhold active medical care at time of enrolment
- Active bleeding with hemodynamic instability at time of enrolment
- Patients with contraindication or known objection to blood transfusions
- SAH due to mycotic aneurysm, infundibulum and vascular malformations.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Liberal RBC Transfusion Strategy
Hemoglobin value of ≤100g/L
|
RBC transfusion is triggered by a Hemoglobin value of ≤100g/L
|
Active Comparator: Restrictive RBC Transfusion Strategy
Hemoglobin value of ≤80g/L
|
Optional RBC transfusion is triggered by a Hemoglobin value of ≤80g/L
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Modified Rankin Scale (mRS)
Time Frame: 12 months post
|
The Modified Rankin Scale (mRS) is a functional outcome measure in stroke. The interview consists of five sections: Constant Care, Assistance to Attend to Bodily Needs/For Walking, Assistance to Look After Own Affairs, Usual Duties and Activities and Symptoms as a Result of Stroke. The scale is scored from 0 reporting no symptoms at all, to 5 reporting severe disability. Death is indicated by a score of 6. |
12 months post
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Functional Independence Measure (FIM)
Time Frame: 12 months post
|
The Functional Independence Measure (FIM) assesses the level of a patient's disability considering the amount of support needed to care for them.Items are scored on the basis of how much assistance is required for the individual to carry out activities of daily living. The FIM is comprised of 18 items, grouped into 2 subscales - motor and cognition. Each item is scored on a 7 point ordinal scale, ranging from 1 to 7. The 2 subscales are then added to give a total FIM score between 18 and 126. The higher the score, the more independent the patient is in performing activities of daily living. |
12 months post
|
EuroQOL Quality of Life Scale (EQ5D)
Time Frame: 12 months post
|
The EQ-5D measures generic health status. There are 5 dimensions: Mobility, Self-care, Usual Activities, Pain/Discomfort and Anxiety/Depression which are answered by 5 Problem Levels: None, Slight, Moderate, Severe and Unable. The result is a 5 digit number, 11111 indicating no problem in any dimension to 55555 indicating unable to complete in all dimensions. Quality of life is also assessed on a visual analog scale reported from 0 being the worst imaginable health status to 100 as the best imaginable health status. |
12 months post
|
Red Blood Cell Transfusions
Time Frame: up to 21 days
|
The total number of red blood cell transfusions received.
|
up to 21 days
|
Daily Hemoglobin
Time Frame: up to 21 days
|
The lowest daily hemoglobin values.
|
up to 21 days
|
Transfusion-related Complications
Time Frame: up to 28 days
|
Complications such as Acute Respiratory Distress Syndrome (ARDS), cardiovascular failure, cardiac ischemia, deep venous thrombosis, pulmonary embolism, sepsis, and septic shock.
|
up to 28 days
|
Delayed Cerebral Ischemia and Vasospasm
Time Frame: up to 28 days
|
The incidence and severity of delayed cerebral ischemia and vasospasm.
|
up to 28 days
|
Cerebral Infarction
Time Frame: up to 28 days
|
The incidence of cerebral infarctions.
|
up to 28 days
|
Mechanical Ventilation
Time Frame: up to 21 days
|
If required, the duration of mechanical ventilation.
|
up to 21 days
|
Length of Stay
Time Frame: 12 months post
|
The length of ICU or hospital stay.
|
12 months post
|
Mortality
Time Frame: 12 months post
|
The number of deaths.
|
12 months post
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Shane English, MD MSc FRCPC, Ottawa Hospital Research Institute
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- CTO:903
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Subarachnoid Hemorrhage, Aneurysmal
-
Medical University InnsbruckRecruitingSubarachnoid Hemorrhage | Subarachnoid Hemorrhage, Aneurysmal | Aneurysmal Subarachnoid Hemorrhage | Vasospasm, CerebralAustria
-
Fondazione Policlinico Universitario Agostino Gemelli...RecruitingSubarachnoid Hemorrhage, Aneurysmal | Subarachnoid Hemorrhage, SpontaneousItaly
-
El Instituto Nacional de Neurologia y Neurocirugia...CompletedBrain Ischemia | Subarachnoid Hemorrhage | Subarachnoid Hemorrhage, Aneurysmal | Delayed Cerebral Ischemia | Aneurysmal Subarachnoid Hemorrhage | Vasospasm, CerebralMexico
-
IRCCS San RaffaeleFondazione Policlinico Universitario Agostino Gemelli IRCCS; Azienda Ospedaliera... and other collaboratorsRecruitingSubarachnoid Hemorrhage, Aneurysmal | Poor Grade Subarachnoid HemorrhageItaly
-
Hackensack Meridian HealthRecruitingStroke | Subarachnoid Hemorrhage, Aneurysmal | Aneurysmal Subarachnoid Hemorrhage | Cerebral Aneurysm | Cerebral Ischemia | Vasospasm, CerebralUnited States
-
University of CalgaryUnknownIntraventricular Hemorrhage | Aneurysmal Subarachnoid HemorrhageCanada
-
Dr. Roman UllrichAustrian Science Fund (FWF)RecruitingSubarachnoid Hemorrhage, AneurysmalAustria
-
Unity Health TorontoWithdrawnSubarachnoid Hemorrhage, AneurysmalCanada
-
National Institute of Mental Health and Neuro Sciences...CompletedSubarachnoid Hemorrhage, AneurysmalIndia
-
Edge Therapeutics IncTerminatedSubarachnoid Hemorrhage, AneurysmalUnited States, Canada, Australia, Hong Kong, Israel, New Zealand, Singapore, Finland, Czechia, Austria, Germany
Clinical Trials on Liberal RBC Transfusion Strategy
-
University of EdinburghNHS Lothian; Chief Scientist Office of the Scottish Government; Transfusion Medicine...CompletedAnemia | Blood Transfusion | Intensive CareUnited Kingdom
-
Guangdong Provincial People's HospitalNot yet recruitingValve Heart Disease | Cardiac Surgery With Cardiopulmonary BypassChina
-
University of Sao PauloCompleted
-
Unity Health TorontoRecruitingCardiac Surgery | Heart | Postoperative | DisorderCanada, Russian Federation
-
Aretaieion University HospitalCompletedSurgery | Cytokine Storm | Infection After Transfusion | Transfusion-related Immunomodulation ReactionGreece
-
Erasme University HospitalEuropean Society of Intensive Care MedicineCompletedBlood Transfusion | Acute Brain InjuryBelgium
-
Unity Health TorontoCompletedDisorder; Heart, Functional, Postoperative, Cardiac SurgeryCanada, Spain, United States, Israel, Australia, New Zealand, Denmark, Colombia, Egypt, Germany, Singapore, Switzerland, China, Brazil, Greece, India, Malaysia, Romania, South Africa
-
Daping Hospital and the Research Institute of Surgery...Children's Hospital of Chongqing Medical UniversityWithdrawnAnemia | Necrotizing Enterocolitis | Red Blood Cell (RBC) TransfusionChina
-
Ottawa Hospital Research InstituteCompletedSubarachnoid HemorrhageCanada
-
Ottawa Hospital Research InstituteCanadian Institutes of Health Research (CIHR); Canadian Blood ServicesActive, not recruitingRed Blood Cell TransfusionCanada